Targin

DRUG3 trials

Sponsors

Mundipharma Korea Ltd, Medical University of Vienna, Assaf-Harofeh Medical Center

Conditions

CancerHeart; Dysfunction Postoperative, Cardiac SurgeryProvide Evidence-based Recommendations for Clinicians to Optimize Pain Control After CXL

Early Phase 1

Pain Relief After Corneal Collagen Cross-Linking

Not yet recruitingNCT06212830

Assaf-Harofeh Medical CenterProvide Evidence-based Recommendations for Clinicians to Optimize Pain Control After CXL

Start: 2024-02-29End: 2025-08-31Target: 51Updated: 2024-01-19

Phase 4

A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

CompletedNCT01675531

Mundipharma Korea LtdCancer

Start: 2012-12-31End: 2014-06-30Updated: 2016-12-16

Oral Oxycodone After Major Cardiac Surgery

CompletedNCT01816581

Medical University of ViennaHeart; Dysfunction Postoperative, Cardiac Surgery

Start: 2011-07-31End: 2013-03-31Updated: 2014-03-26